BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2024 12:59:17 PM | Browse: 250 | Download: 934
 |
Received |
|
2024-05-06 09:47 |
|
Peer-Review Started |
|
2024-05-17 03:24 |
|
First Decision by Editorial Office Director |
|
2024-06-14 05:57 |
|
Return for Revision |
|
2024-06-14 05:57 |
|
Revised |
|
2024-06-24 18:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-07-22 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-07-23 10:18 |
|
Articles in Press |
|
2024-07-23 10:18 |
|
Edit the Manuscript by Language Editor |
|
2024-07-25 10:51 |
|
Typeset the Manuscript |
|
2024-07-31 02:36 |
|
Publish the Manuscript Online |
|
2024-08-26 12:59 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Tissue-source effect on mesenchymal stem cells as living biodrugs for heart failure: Systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Moaz Safwan, Mariam Safwan Bourgleh, Mohamed Aldoush and Khawaja Husnain Haider |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Khawaja Husnain Haider, PhD, Professor, Department of Basic Sciences, Sulaiman Al Rajhi University, PO Box 777, Al Bukairiyah 51941, Saudi Arabia. kh.haider@sr.edu.sa |
| Key Words |
Cardiovascular; Clinical; Heart; Mesenchymal; Umbilical cord; Randomized; Stem cells |
| Core Tip |
Mesenchymal stem cells (MSCs) are fast emerging as living biodrugs to repair and replace dysfunctional myocardium. While MSCs are available from diverse adult and fetal tissues, bone marrow-derived MSCs (BM-MSCs; adult tissue source) and umbilical cord-derived MSCs (UC-MSCs; fetal tissue source) remain the most well-studied types during recent clinical trials. The primary aim of this systematic review and meta-analysis was to evaluate the comparative safety and effectiveness of BM-MSCs and UC-MSCs-based therapy in heart failure patients analyzing left ventricular ejection fraction, 6-minute walk distance as the primary functional and clinical outcomes. |
| Publish Date |
2024-08-26 12:59 |
| Citation |
Safwan M, Bourgleh MS, Aldoush M, Haider KH. Tissue-source effect on mesenchymal stem cells as living biodrugs for heart failure: Systematic review and meta-analysis. World J Cardiol 2024; 16(8): 469-483 |
| URL |
https://www.wjgnet.com/1949-8462/full/v16/i8/469.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v16.i8.469 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
